CX-5011

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameCX-5011
Drug Alias NameCX-5011
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCasein kinase II inhibitors
TargetsCasein kinase II
Therapy Area/IndicationsPainInflammationNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCylene Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCylene Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsPainInflammationNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A